Herbst Timothy

recently stated that they own 10.8% of Creative Medical Technology Holdings Inc (OTCMKTS:CELZ) in a Form 13G/A disclosure that was filed with the Securities and Exchange Commission on Monday, December 18th. The investor owns 11,346,677 shares of the stock valued at approximately $289,340. The filing is available through Edgar at this link.

Creative Medical Technology Holdings Inc (OTCMKTS:CELZ) remained flat at $$0.03 during trading hours on Monday. 23,047 shares of the company’s stock traded hands, compared to its average volume of 59,757. Creative Medical Technology Holdings Inc has a 52 week low of $0.01 and a 52 week high of $0.70.

ILLEGAL ACTIVITY NOTICE: “10.8% Stake of Creative Medical Technology Holdings Inc (CELZ) Held by Herbst Timothy” was first reported by Watch List News and is owned by of Watch List News. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://www.watchlistnews.com/10-8-stake-of-creative-medical-technology-holdings-inc-celz-held-by-herbst-timothy/1771435.html.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc, formerly Jolley Marketing, Inc, is a clinical-stage company. The Company conducts its business operations primarily through its subsidiary, Creative Medical Technologies, Inc (CMT). The Company is engaged in stem cell research and applications for use to treat male and female sexual dysfunction, infertility, miscarriages and related issues.

Want to see what other hedge funds are holding CELZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Creative Medical Technology Holdings Inc (OTCMKTS:CELZ).

Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.